Preliminary Results Of A Phase 1b Study (Go28440) Combining Gdc-0199 (Abt-199) With Bendamustine/Rituximab In Patients With Relapsed/Refractory Or Previously Untreated Chronic Lymphocytic Leukemia
BLOOD(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要